|
π¬
|
Activation and clinical significance of the unfolded protein response in breast cancer
P. Scriven,
S. Coulson,
R. Haines,
S. Balasubramanian,
S. Cross,
L. Wyld
|
7 |
2009 |
7
π¬
|
|
π
|
Osteoprotegerin (OPG) Expression by Breast Cancer Cells in vitro and Breast Tumours in vivo β A Role in Tumour Cell Survival?
10 auth.
I. Holen,
S. Cross,
H. Neville-Webbe,
N. Cross,
S. Balasubramanian,
P. Croucher,
...
C. Evans,
J. Lippitt,
R. E. Coleman,
C. Eaton
|
6 |
2005 |
6
π
|
|
π¦
|
Osteoprotegerin (OPG)βa potential new role in the regulation of endothelialcell phenotype and tumour angiogenesis?
11 auth.
S. Cross,
Zhiyong Yang,
Nicola J Brown,
S. Balasubramanian,
C. A. Evans,
J. Woodward,
...
H. Neville-Webbe,
J. Lippitt,
M. Reed,
R. E. Coleman,
I. Holen
|
6 |
2006 |
6
π¦
|
|
π
|
Different molecular profiles are associated with breast cancer cell homing compared with colonisation of bone: evidence using a novel bone-seeking cell line.
11 auth.
F. Nutter,
I. Holen,
H. Brown,
S. Cross,
C. Evans,
M. Walker,
...
R. E. Coleman,
Jules A. Westbrook,
P. Selby,
Janet E Brown,
P. Ottewell
|
6 |
2014 |
6
π
|
|
π
|
Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor ΞΊB ligand (RANKL) in human breast tumours
8 auth.
C. Poznak,
S. Cross,
M. Saggese,
C. Hudis,
K. Panageas,
L. Norton,
...
R. Coleman,
I. Holen
|
6 |
2006 |
6
π
|
|
π
|
A zebrafish model to study and therapeutically manipulate hypoxia signaling in tumorigenesis.
10 auth.
Kirankumar Santhakumar,
E. Judson,
P. Elks,
Sarah McKee,
S. Elworthy,
Ellen van Rooijen,
...
S. Walmsley,
S. Renshaw,
S. Cross,
F. V. van Eeden
|
6 |
2012 |
6
π
|
|
π¬
|
Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model
P. Ottewell,
Diane V. Lefley,
S. Cross,
C. Evans,
R. E. Coleman,
I. Holen
|
6 |
2010 |
6
π¬
|
|
π
|
S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors
10 auth.
I. Rehman,
S. Cross,
A. Azzouzi,
J. Catto,
J. Deloulme,
S. LarrΓ©,
...
J. Champigneuille,
Gaelle Fromont,
O. Cussenot,
F. Hamdy
|
5 |
2004 |
5
π
|
|
π
|
Dystroglycan function is a novel determinant of tumor growth and behavior in prostate cancer
7 auth.
A. Mitchell,
G. Mathew,
T. Jiang,
F. Hamdy,
S. Cross,
C. Eaton,
...
Steve J. Winder
|
4 |
2013 |
4
π
|
